TORONTO–(BUSINESS WIRE)–BioPharma Services is proud to once again be the recipient of the CRO
Leadership Award. This year, BioPharma has been recognized with awards
in five categories: Capabilities, Compatibility, Expertise, Quality
and Reliability. Renzo Dicarlo, CEO will be accepting the Award from
Life Science Leader at the annual CRO Leadership Awards presentation
which takes place during the upcoming DIA Global Annual Meeting in San
Diego.
On receiving notification of the Awards, Renzo Dicarlo enthused, “We are
humbled to be recognized by our peers in a record five categories of the
CRO Leadership Awards. BioPharma’s commitment to deliver excellence in
early stage research is reaffirmed daily by an empowered team that
always goes the extra mile while delivering world class clinical
solutions for our clients. I could not be more proud today of this
achievement”.
Anna Taylor, BioPharma’s Executive Vice President Business Development
noted, “Inspired performance, quality and innovation are the hallmarks
of BioPharma. Every day, the team strives to develop leading-edge
healthcare solutions and essential medical therapies for the global
pharmaceutical community and most recently has been responsible for our
groundbreaking Phase I and Human Abuse Potential service offerings.
Receiving these Awards cements BioPharma Services as a true leader in
this niche market”.
For the 2019 Awards, Life Science Leader magazine once again teamed up
with Industry Standard Research (ISR) to determine the award recipients.
More than 70 contract research organizations were assessed on 20+
performance metrics in ISR’s annual CRO Quality Benchmarking survey.
Survey participants were recruited from Pharma and Biopharma companies
of all sizes and were screened for decision-making influence related to
working with contract research organizations. Respondents only evaluate
companies with which they have worked on an outsourced project within
the past 18 months. This level of qualification ensures that survey
responses are based on actual involvement with CROs and clear
experiential data.
About BioPharma Services Inc.
BioPharma Services Inc. is a
full-service Contract Research Organization (CRO) specializing in the
conduct of Phase I/IIa and Bioequivalence clinical trials for
international pharmaceutical companies worldwide. BioPharma has clinical
facilities both in the USA and Canada with a total capacity of 300 beds
with access to healthy volunteers and special populations. Headquartered
in Toronto, Canada, BioPharma’s comprehensive services also include
Bioanalysis at our GLP Certified Laboratory, Scientific and Regulatory
Affairs, Biostatistics and Safety Data Analysis (CDISC), Medical Writing
and Data Management.
Contacts
Ms. Anna Taylor, Executive Vice President, Business Development,
BioPharma Services, Inc.
ataylor@biopharmaservices.com
Main
Telephone: +1 844 747 8484
Email: info@biopharmaservices.com
Website:
www.biopharmaservices.com